# RxData attends EPA 2025 in Amsterdam

_Conferences | March 4, 2025_

RxData is in attendance at the 2025 World EPA conference in Amsterdam. This year we have CEO Tommaso Albonetti following up on last year's EPA with a presentation of new research and an updated model entitled "Using G-BA assessment data to model oncology pricing in Germany 2017-2025: Insights and forecasts." Stay tuned to find the presentation coming soon to rxdata.net!

### Press Releases

- [ISPOR 2023 - Impacting Innovation, Value and Healthcare Decision Making](/content/blog/ispor-2023-impacting-innovation-value-and-healthcare-decision-making/index.html)
- [RxData and Edra enter into a long-term partnership](/content/blog/rxdata-and-edra-enter-long-term-partnership/index.html)
- [RxData leverages First Databank content for its U.S. drug pricing component](/content/blog/rxdata-leverages-first-databank-content-its-us-drug-pricing-component/index.html)
- [Seed Round of Capital](/content/blog/seed-round-capital/index.html)
- [RxData news in Switzerland](/content/blog/rxdata-news-switzerland/index.html)
- [RxData joins Blueprint Health accelerator](/content/blog/rxdata-joins-blueprint-health-accelerator/index.html)